Global Drug-Eluting Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 to 2025

Global Drug-Eluting Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 to 2025

This report studies the global market size of Drug-Eluting Stents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug-Eluting Stents in these regions.

This research report categorizes the global Drug-Eluting Stents market by top players/brands, region, type and end user. This report also studies the global Drug-Eluting Stents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.

North America dominated the global Drug Eluting Stent Market with a revenue share of 37% in 2017. The dominance of the region was majorly attributed to stringent regulatory guidelines for medical device manufacturing and approval. In addition, the reimbursement coverage coupled with a high incidence rate of artery diseases is anticipated to augment the market growth in North America.

Request Sample Report @ http://www.orbisresearch.com/contacts/request-sample/2304532
The global Drug-Eluting Stents market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Drug-Eluting Stents market based on company, product type, end user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Boston Scientific

Medtronic, Inc.

Abbott

Lepu Medical

MicroPort Scientific Corporation

Cook Medical

Terumo

Biosensors International

Balton

AlviMedica Medical Technologies

Biotronik

Shandong JW Medical

Sino Medical

Beijing AMSINO

Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

 

Browse Complete Report@ http://www.orbisresearch.com/reports/index/global-drug-eluting-stents-market-insights-forecast-to-2025

 

Market size by Product

Rapamycin

Paclitaxel

Everolimus

Others

 

Market size by End User

Angina Pectoris

Myocardial Infarction

 

Enquiry Before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2304532

 

Some Points From Table of Content:

Chapter One: Study Coverage

Chapter Two: Executive Summary

Chapter Three: Breakdown Data by Manufacturers

Chapter Four: Breakdown Data by Product

Chapter Five: Breakdown Data by End User

Chapter Six: North America

Chapter Seven: Europe

Continued…

 

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

 

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9120641 01019

Email id:  sales@orbisresearch.com